Nationwide quality assessment of treatment for chronic obstructive pulmonary disease.

Conclusions: The PFT and inhaled bronchodilator prescription rates improved over the 3-year nationwide quality assessment period. PMID: 33447406 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/33447406?dopt=Abstract

Source: Journal of Thoracic Disease - January 17, 2021 Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research

More News: Chronic Obstructive Pulmonary | Health Insurance | Insurance | Pulmonary Function Testing | Respiratory Medicine